Andrew Senn Sells 5,000 Shares of Integer Holdings Co. (NYSE:ITGR) Stock

Integer Holdings Co. (NYSE:ITGR) SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the sale, the senior vice president now directly owns 4,658 shares in the company, valued at approximately $527,006.12. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Integer Price Performance

ITGR stock traded up $1.02 on Thursday, hitting $114.16. 174,136 shares of the company’s stock traded hands, compared to its average volume of 336,473. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. The stock has a market cap of $3.82 billion, a price-to-earnings ratio of 39.15, a P/E/G ratio of 1.65 and a beta of 1.12. The stock has a fifty day moving average of $114.66 and a 200-day moving average of $101.98. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $123.99.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. During the same quarter last year, the company posted $0.87 EPS. Integer’s revenue for the quarter was up 9.5% on a year-over-year basis. On average, analysts forecast that Integer Holdings Co. will post 5.27 EPS for the current fiscal year.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Integer by 497.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider’s stock valued at $42,065,000 after buying an additional 446,508 shares in the last quarter. Public Employees Retirement Association of Colorado boosted its holdings in shares of Integer by 3,260.1% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after purchasing an additional 276,944 shares during the period. Norges Bank acquired a new position in Integer in the 4th quarter valued at approximately $18,697,000. Victory Capital Management Inc. increased its stake in shares of Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider’s stock worth $128,041,000 after acquiring an additional 133,898 shares during the last quarter. Finally, FMR LLC boosted its position in Integer by 12.8% during the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider’s stock valued at $67,759,000 after purchasing an additional 97,851 shares during the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. CL King initiated coverage on shares of Integer in a research note on Thursday, March 14th. They set a “buy” rating and a $137.00 price objective on the stock. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Benchmark reiterated a “buy” rating and issued a $130.00 price objective on shares of Integer in a report on Friday, April 26th. Finally, KeyCorp boosted their target price on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $120.50.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.